Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04197479 |
|---|---|
| Brief Title: | A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients (MAESTRO-NAFLD1) |
| First Submitted : | December 11, 2019 |
| First Submitted that Met QC Criteria : | December 11, 2019 |
| First Posted : | December 13, 2019 |
| Last Update Submitted that Met QC Criteria : | August 30, 2023 |
| Last Update Posted : | September 5, 2023 |